Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SUNSET Goes Dark: HHS Withdraws Controversial Regulatory Review Rule

Executive Summary

The US Department of Health and Human Services said the rule, which would require most regulations be reviewed every 10 years, would gobble departmental resources and could hurt the public health.

You may also be interested in...



Sunset for SUNSET? Implementation Of Reg Review Policy Delayed To 2022 Pending Legal Battle

The US Department of Health and Human Services says trying to implement the rule while it is still being litigated could create confusion for the public, among other problems.

With Sun Setting On Trump Admin, HHS Finalizes Regulatory Review Rule

In a change from the draft, the final rule exempts device-specific regulations from scheduled review.

US FDA Classifies 5 De Novo-Cleared Device Types

The five products include a conditioning tool for eating disorders, a system that evaluates the properties of esophogeal tissue, and a tool used to measure the strain on an orthopedic implant during surgery.

Topics

UsernamePublicRestriction

Register

MT144665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel